You have 9 free searches left this month | for more free features.

Atopic Dermatitis Eczema

Showing 1 - 25 of 3,348

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp Trial (HY209GEL Active, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • +2 more
  • HY209GEL Active
  • Placebo
  • (no location specified)
Aug 31, 2023

Atopic Dermatitis, Atopic Dermatitis Eczema Trial in Rotterdam (Dupilumab)

Not yet recruiting
  • Atopic Dermatitis
  • Atopic Dermatitis Eczema
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Aug 22, 2023

Atopic Dermatitis Eczema, Atopic Dermatitis Trial (NB-UVB phototherapy, Optimal topical therapy)

Not yet recruiting
  • Atopic Dermatitis Eczema
  • Atopic Dermatitis
  • NB-UVB phototherapy
  • Optimal topical therapy
  • (no location specified)
Jan 19, 2023

Atopic Dermatitis Eczema Trial in Columbus (Arctiva)

Completed
  • Atopic Dermatitis Eczema
  • Arctiva
  • Columbus, Ohio
    ClinOhio Research Services, LLC
Jun 23, 2023

Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema Trial in San Francisco (Dupilumab)

Recruiting
  • Atopic Dermatitis
  • +3 more
  • San Francisco, California
    UCSF Psoriasis and Skin Treatment Center
Jan 25, 2023

Cutaneous Nerves CNS Itch Trial in Minneapolis (Clonidine, Naltrexone)

Completed
  • Cutaneous Nerves CNS Itch
  • Minneapolis, Minnesota
    University of Minnesota Department of Dermatology
Jan 23, 2023

Atopic Dermatitis, Atopic Dermatitis Eczema Trial in San Francisco (Dupilumab)

Completed
  • Atopic Dermatitis
  • Atopic Dermatitis Eczema
  • San Francisco, California
    UCSF Psoriasis and Skin Treatment Center
Jan 5, 2023

Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis Flare Trial in Copenhagen NV (Dicloxacillin Oral Capsule, Elocon

Recruiting
  • Atopic Dermatitis
  • +2 more
  • Dicloxacillin Oral Capsule
  • Elocon 0.1 % Topical Cream
  • Copenhagen NV, Denmark
    Department of Dermatology
Dec 20, 2022

Atopic Dermatitis, Atopic Dermatitis Eczema Trial (Lactic acid bacteria NTU 101, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Atopic Dermatitis Eczema
  • Lactic acid bacteria NTU 101
  • Placebo
  • (no location specified)
Jan 30, 2023

Atopic Dermatitis Eczema Trial in London (Nocturnal Temperature controlled Laminar Airflow (TLA) Treatment, Placebo TLA Device)

Recruiting
  • Atopic Dermatitis Eczema
  • Nocturnal Temperature controlled Laminar Airflow (TLA) Treatment
  • Placebo TLA Device
  • London, United Kingdom
    IMPERIAL COLLEGE HEALTHCARE NHS Trust
Sep 22, 2022

Atopic Dermatitis, Atopic Dermatitis Eczema Trial in Irvine (Crisaborole 2% Top Oint, Skin Microbiome Swabs)

Active, not recruiting
  • Atopic Dermatitis
  • Atopic Dermatitis Eczema
  • Crisaborole 2% Top Oint
  • Skin Microbiome Swabs
  • Irvine, California
    University of California, Irvine - Dermatology Clinical Research
Feb 28, 2022

Atopic Dermatitis Eczema Trial in Montréal (BBI-02 Capsule, Placebo)

Recruiting
  • Atopic Dermatitis Eczema
  • FRTX-02 Capsule
  • Placebo
  • MontrĂ©al, Quebec, Canada
    Syneos Health Quebec
Sep 12, 2022

Atopic Dermatitis Trial (Cosmetic Product TOPIALYSE Baume Protect+)

Not yet recruiting
  • Atopic Dermatitis
  • Cosmetic Product TOPIALYSE Baume Protect+
  • (no location specified)
Oct 25, 2023

Atopic Dermatitis Trial

Not yet recruiting
  • Atopic Dermatitis
    • (no location specified)
    Nov 16, 2023

    Atopic Dermatitis, Eczema Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Roseomonas mucosa

    Not yet recruiting
    • Atopic Dermatitis
    • Eczema
    • Roseomonas mucosa (RSM2015) and Cardamom seeds
    • Placebo (sucrose)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 27, 2023

    Atopic Dermatitis, Eczema Trial (Lebrikizumab)

    Not yet recruiting
    • Atopic Dermatitis
    • Eczema
    • Lebrikizumab
    • (no location specified)
    Aug 7, 2023

    Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Rash Trial in Dhaka (Fexofenadine Hydrochloride Topical Lotion 1% (OP2101))

    Recruiting
    • Atopic Dermatitis
    • +11 more
    • Fexofenadine Hydrochloride Topical Lotion 1% (OP2101)
    • Dhaka, Ramna, Bangladesh
      BCT Ltd.
    Jul 13, 2022

    Skin Microbes in Healthy People and in People With Skin

    Recruiting
    • Atopic Dermatitis
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)

      Not yet recruiting
      • Atopic Dermatitis
      • Dupilumab - Discontinuation
      • +2 more
      • (no location specified)
      Nov 2, 2023

      Insulin Resistance in Atopic Dermatitis Patients

      Recruiting
      • Atopic Dermatitis
        • Istanbul, Turkey
          Bezmialem Vakif University Hospital
        Jun 6, 2023

        Atopic Dermatitis Trial in Nice (Blood sample)

        Not yet recruiting
        • Atopic Dermatitis
        • Blood sample
        • Nice, France
          Nice University Hospital
        May 11, 2023

        Atopic Dermatitis Trial (CM310)

        Not yet recruiting
        • Atopic Dermatitis
        • CM310
        • (no location specified)
        Oct 30, 2023

        Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)

        Not yet recruiting
        • Atopic Dermatitis
        • Baricitinib 4 MG
        • Azathioprine 1.5-2.5 mg/kg
        • Sari, Mazandaran, Iran, Islamic Republic of
          Iran
        Aug 1, 2023

        Atopic Dermatitis, Eczema-Prone Skin Trial in Schenefeld (Body Lotion and Intensive Care)

        Active, not recruiting
        • Atopic Dermatitis
        • Eczema-Prone Skin
        • Body Lotion and Intensive Care
        • Schenefeld, Germany
          SGS proderm GmbH
        Mar 28, 2023

        Dupilumab in Participants =6 Years With Atopic Dermatitis

        Recruiting
        • Atopic Dermatitis
          • Berlin, Germany
            Investigational Site Number :
          Sep 18, 2023